ICYMI: The Atlantic – Big Pharma’s Go-To Defense of Soaring Drug Prices Doesn’t Add Up
Just how expensive do prescription drugs need to be to fund innovative… Read More
© 2026 CSRXP- All Rights Reserved
They Said It! Lawmakers Advance Key Drug Pricing Bills
House Energy & Commerce Members Recommit To Bipartisan Action As Critical… Read More
CSRxP Applauds House Lawmakers For Keeping Momentum Going On Key Drug Price Legislation
U.S. House Committee On Energy & Commerce Health Subcommittee Will Markup… Read More
ICYMI: Drug Prices Are A Matter Of Life And Death
The Hill Lauren Aronson March 21, 2019 https://thehill.com/blogs/congress-blog/4… Read More
ICYMI: Lack Of Competition In Drug Market Drives Up Medicare & Medicaid Spending
In case you missed it, the Centers for Medicare and Medicaid Services (CMS)… Read More
Good Medicine: Congress Should Pass Market-Based Solutions to Spur Prescription Drug Competition
The Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act… Read More
CSRxP: Legislative Hearing on Drug Pricing Bills a Positive First Step, Now More Action Needed
Today, members of the U.S. House Committee on Energy & Commerce… Read More
Second Opinion: Rebate Rule Will Hike Premiums On Seniors
Lowering prescription drug prices is a laudable focus of the Trump… Read More
Questioning The Rebate Rule
Secretary Azar Recently Noted The Effectiveness Of PBMs Now Targeted By Agency… Read More
Trump Administration Should Focus on Market-Based Solutions to Alleviate Drug Prices
As Secretary Azar Heads To Capitol Hill, CSRxP Encourages Lawmakers To… Read More
Headlines: Lawmakers, Patients, Experts Keep-Up Drumbeat For Action On Drug Prices
Three More Congressional Hearings Tackle Big Pharma’s Anti-Competitive… Read More
ICYMI: House Judiciary Subcommittee on Anti-Trust Members Tout Benefits of CREATES Act
During today’s House Judiciary Subcommittee on Anti-trust hearing on… Read More